This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Christopher Barbosa, Ph.D.
Director of Technology Development at Acuitas Therapeutics


Dr. Barbosa is the Director, Technology Development at Acuitas Therapeutics, a worldwide leader in the development of lipid nanoparticle formulations for delivery of nucleic acids. Prior to joining Acuitas, Dr. Barbosa’s experience spans the development of products related to small molecule therapeutics in lipid nanoparticles, drug/device combination products and biopesticides, with generally common focus on CMC aspects related to analytical characterization, formulation development and process development.

Agenda Sessions

  • A Novel Vaccine Approach Using Messenger RNA‐Lipid Nanoparticles: Preclinical and Clinical Perspective